Caredx Inc buy BiotechBee
Start price
19.08.24
/
70%
€30.31
Target price
31.10.26
€40.00
Performance (%)
-18.15%
End price
08.09.24
€24.81
Summary
This prediction ended on 08.09.24 with a price of €24.81. The price of Caredx Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.15%. BiotechBee has 70% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Caredx Inc | 14.025% | 14.025% | -19.559% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to BiotechBee what are the pros and cons of Caredx Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Caredx Inc diskutieren
Buy mit Kursziel 40,0